Pharmacokinetic-guided dose reduction of emicizumab in congenital hemophilia A: Interim Analysis of the DosEmi Study.
van der Zwet K, de Vos ADW, Cnossen MH, Heubel-Moenen FCJI, Schols SEM, Ypma PF, den Exter PL, Hooimeijer HL, Coppens M, Mathôt RAA, Janssen A, Donners AAMT, Kruis I, Urbanus RT, van Vulpen LFD, Eckhardt CL, Schutgens REG, Fischer K; OPTI-CLOT Study Group and SYMPHONY Consortium.
van der Zwet K, et al. Among authors: janssen a.
J Thromb Haemost. 2025 Nov 7:S1538-7836(25)00829-3. doi: 10.1016/j.jtha.2025.10.029. Online ahead of print.
J Thromb Haemost. 2025.
PMID: 41207564
Free article.